GAMA LG, CABO CJ. Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study. J Hosp Pharm Health Serv [Internet]. 2025 Jun. 24 [cited 2025 Dec. 1];16(2):e1259. Available from: https://jhphs.org/sbrafh/article/view/1259